Nationwide Fund Advisors - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 85 filers reported holding CTI BIOPHARMA CORP in Q3 2014. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2016$79,000
-51.2%
148,412
+12.7%
0.00%
-100.0%
Q4 2015$162,000
+2.5%
131,680
+21.8%
0.00%0.0%
Q3 2015$158,000
-25.1%
108,1060.0%0.00%0.0%
Q2 2015$211,000
+5.5%
108,106
-2.4%
0.00%0.0%
Q1 2015$200,000
-24.5%
110,766
-1.2%
0.00%0.0%
Q4 2014$265,000
+5.6%
112,127
+8.3%
0.00%0.0%
Q3 2014$251,000
-13.1%
103,575
+0.8%
0.00%0.0%
Q2 2014$289,000102,7780.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2014
NameSharesValueWeighting ↓
PYRRHO CAPITAL MANAGEMENT, LP 608,194$1,186,0000.58%
Lombard Odier Asset Management (USA) Corp 2,768,341$5,398,0000.38%
Rotella Capital Management, Inc. 43,666$85,0000.07%
TWO SIGMA SECURITIES, LLC 19,994$39,0000.06%
OXFORD ASSET MANAGEMENT LLP 1,214,227$2,368,0000.06%
Candriam S.C.A. 1,445,000$2,818,0000.06%
WASHINGTON TRUST Co 410,616$801,0000.05%
DRW Securities, LLC 250,000$488,0000.05%
GLOBEFLEX CAPITAL L P 120,000$234,0000.04%
First Heartland Consultants, Inc. 74,624$146,0000.04%
View complete list of CTI BIOPHARMA CORP shareholders